Wellgistics Health, Inc., a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a groundbreaking initiative to adopt XRP as both a treasury reserve and a real-time payments infrastructure.
Upon successful commercialization, this move would make Wellgistics one of the first publicly-traded healthcare companies to deploy XRP in such a transformative capacity.
This initiative is supported by Wellgistics Health’s $50 million Equity Line of Credit (ELOC), which would be used to further develop and unlock programmable liquidity and on-demand financial infrastructure.
The goal is to eliminate banking delays, reduce operational costs, and increase transparency across the company’s national healthcare ecosystem. “At Wellgistics Health, we challenge the idea that healthcare has to be tethered to legacy systems, bloated intermediaries, and slow-moving money,” said Brian Norton, CEO of Wellgistics Health.
He added: “We are developing a platform that connects manufacturers directly to pharmacies and patients—bypassing the red tape and placing control back in the hands of those who deliver care. Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three. I believe that the future winners in healthcare won’t be the companies with the biggest buildings…they’ll be those with the fastest rails, cleanest data, and most efficient platforms. We’re betting on infrastructure…not inertia.”
Read also: Ethereum and XRP Shine as Digital Asset Inflows Hit $2 Billion in a Week
Wellgistics sees clear advantages in XRP integration
According to Wellgistics, XRP offers distinct advantages in healthcare financial infrastructure. First, its near-instant settlement time allows for real-time financial coordination between pharmacies, manufacturers, and suppliers. Notably, XRP has a 3-5 seconds transaction finality compared to 1-3 days processing time when using traditional rails.
Second, transaction costs on the XRP Ledger (XRPL) network are a fraction ($0.0002) of traditional methods ($10-$30). Moreover, every transfer is recorded on the XRPL to support compliance, transparency and auditability.
Third, the system also facilitates global payouts, offers programmable rebates, and enables XRP-backed lines of credit to support liquidity for independent pharmacies.
Per the announcement, these XRP capabilities will be deployed across various functions in the Wellgistics ecosystem, including real-time vendor payments, performance-based rebate execution, and automated compliance with the Drug Supply Chain Security Act (DSCSA).
The company also aims to enable global vendor settlements at near-zero cost while enhancing data transparency throughout the healthcare supply chain.“We’re working to unlock capital velocity with surgical precision,” said Mark DiSiena, CFO of Wellgistics Health. “We believe that our XRP-powered infrastructure will allow us to run leaner, faster, and with more control than any of our peers in pharma infrastructure.”
Read also: Brazil Beats the U.S. to Launch First-Ever Spot XRP ETF
Institutional momentum builds around XRP
Wellgistics’ XRP integration in healthcare payment and treasury infrastructure comes amid growing institutional momentum for the third-largest crypto asset by market cap.
Notably, in April 2025, Bitcoin exchange-traded fund (ETF) issuer ProShares launched three futures XRP ETFs. In May 2025, CME Group is set to launch cash-settled XRP futures to meet institutional demand.
Additionally, Mastercard’s 2025 report identifies XRP as a bridge currency for cost-effective cross-border payments. Ripple, the company behind XRP, has also announced a $1.25 billion acquisition of prime brokerage firm Hidden Road and secured a regulatory license in Dubai to offer crypto-based financial services. Ripple also expanded real-world payment corridors in Brazil and Portugal through a strategic partnership with Unicâmbio.
